Delivery Order SPE2DB20D3101-SPE2DB24FQVC1
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $24,585.28 and has an ultimate completion date of October 20, 2023. The contract is for the supply of Cephalexin 250 mg/5 ml suspension in 200 ml bottles. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,314,953 units of Cephalexin 500 mg capsules. The contract has a firm fixed price of $4,979.51 and a performance period that runs through August 2, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
- This federal contract award, valued at $30,867.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563207552 - CEPHALEXIN 250 MG/5 ML SUSP 100ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of January 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $1,789.64, is for the delivery of 4,563,942,071 units of the pharmaceutical product Cephalexin 250 mg/5 ml suspension in 100 ml containers. This delivery order does not have a set-aside designation. The award is part of a larger, single-award indefinite...
- This federal contract award, with an ID of SPE2DB22D3016|SPE2DB24FABX5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cephalexin 250 mg/5 ml suspension in 100 ml bottles, with a ceiling value of $15,100.92 and an ultimate completion date of October 31, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,712.86 firm-fixed-price delivery order is for the supply of 4561247098 - Cephalexin 250 mg/5 ml suspension, 200 ml, with a period of performance through June 15, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,842.32 Firm Fixed Price Delivery Order is for the supply of 4559601323 - Cephalexin 250 mg/5 ml Suspension, 200 ml. The award is not designated as a set-aside contract. It represents a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $5,367.46 firm fixed-price delivery order is for the supply of 4,565,696,333 milliliters of Cephalexin 125 mg/5 ml suspension, a common antibiotic medication. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999, that...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560923549 - Cephalexin 250 mg/5 ml Suspension 200 ml, a pharmaceutical product. The contract has a ceiling value of $6,824.81 and is a Firm Fixed Price Delivery Order, with a period of performance through May 15, 2023. The contract was awarded on May 12, 2023 and was not set aside for any specific...
- The Defense Logistics Agency awarded a $1,167.36 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for 500 capsules of Cephalexin 250 mg, an oral antibiotic commonly used to treat bacterial infections. This non-set-aside contract is priced on a firm fixed-price basis and has a completion date of December 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQVC1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $2,489.91, is a delivery order for 4,562,888,391 units of Cephalexin 250 mg capsules. The contract has an ultimate completion date of November 24, 2023 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 11/22/23 |